Please refer the attached intimation.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.2 pts less than Nifty Microcap 250 and 0.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Transchem Limited has informed the stock exchange that its statutory auditor, M/s. SPML & Associates, Chartered Accountants (FRN: 136549W), has resigned with immediate effect from June 20, 2025. The auditor was originally appointed for a 5-year term at the July 29, 2023 AGM, covering FY2023-24 to FY2027-28, meaning this is a midterm exit nearly three years ahead of schedule. SPML & Associates cited pre-occupation with other professional commitments and their inability to audit the company's financial statements from FY2025-26 onwards as the reason. Importantly, the auditor confirmed they had no concerns with the company, having already completed and signed off on the FY2024-25 audit (report dated May 20, 2025). The company stated that the Audit Committee and Board will take note of the resignation and recommend the appointment of a new statutory auditor for shareholder approval.
This is a routine auditor change and not a red flag, since the auditor resigned due to their own workload constraints and explicitly stated there were no concerns. However, shareholders should watch for the timely appointment of a replacement auditor to avoid any disruption to the FY2025-26 audit cycle.